摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Furan-2-yl-7-[2-(2,4,5-tribromo-phenyl)-ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine | 181622-15-1

中文名称
——
中文别名
——
英文名称
2-Furan-2-yl-7-[2-(2,4,5-tribromo-phenyl)-ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine
英文别名
4-(Furan-2-yl)-10-[2-(2,4,5-tribromophenyl)ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaene
2-Furan-2-yl-7-[2-(2,4,5-tribromo-phenyl)-ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine化学式
CAS
181622-15-1
化学式
C18H11Br3N6O
mdl
——
分子量
567.037
InChiKey
VKIFWQIMFQETKV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    74
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of the tritium labeled SCH 58261, a new non-xanthine A2A adenosine receptor antagonist
    摘要:
    The tritium labeled form of 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e] 1,2,4-triazolo[1,5-c]pyrimidine (H-3-SCH 58261) was obtained by reduction of 5-amino-7-[2-(2',4',5'-tribromo)-phenylethyl]-2-(2-furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine with tritium gas in the presence of 10% Pd-C. Final product was purified by HPLC to give the title H-3-SCH 58261 with radiochemical purity of 99% and specific activity of 68.6 Ci/mmol. H-3-SCH 58261 bound A(2A) receptors in rat striatal membranes (specific binding > 90%) with K-d acid B-max value of 0.70 nM and 971 fmol/mg of protein, respectively. H-3-SCH 58261 represents a useful tool for a further characterization of A(2A) adenosine receptor subtype.
    DOI:
    10.1002/(sici)1099-1344(199608)38:8<725::aid-jlcr885>3.0.co;2-g
  • 作为产物:
    参考文献:
    名称:
    Synthesis of the tritium labeled SCH 58261, a new non-xanthine A2A adenosine receptor antagonist
    摘要:
    The tritium labeled form of 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e] 1,2,4-triazolo[1,5-c]pyrimidine (H-3-SCH 58261) was obtained by reduction of 5-amino-7-[2-(2',4',5'-tribromo)-phenylethyl]-2-(2-furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine with tritium gas in the presence of 10% Pd-C. Final product was purified by HPLC to give the title H-3-SCH 58261 with radiochemical purity of 99% and specific activity of 68.6 Ci/mmol. H-3-SCH 58261 bound A(2A) receptors in rat striatal membranes (specific binding > 90%) with K-d acid B-max value of 0.70 nM and 971 fmol/mg of protein, respectively. H-3-SCH 58261 represents a useful tool for a further characterization of A(2A) adenosine receptor subtype.
    DOI:
    10.1002/(sici)1099-1344(199608)38:8<725::aid-jlcr885>3.0.co;2-g
点击查看最新优质反应信息

文献信息

  • Pyrazolo[4,3-<i>e</i>]1,2,4-triazolo[1,5-<i>c</i>]pyrimidine Derivatives as Highly Potent and Selective Human A<sub>3</sub> Adenosine Receptor Antagonists:  Influence of the Chain at the N<sup>8</sup> Pyrazole Nitrogen
    作者:Pier Giovanni Baraldi、Barbara Cacciari、Romeo Romagnoli、Giampiero Spalluto、Stefano Moro、Karl-Norbert Klotz、Edward Leung、Katia Varani、Stefania Gessi、Stefania Merighi、Pier Andrea Borea
    DOI:10.1021/jm001047y
    日期:2000.12.1
    IB-MECA was measured in membranes of CHO cells stably transfected with the human A(3) receptor. The new compounds are among the most potent and selective A(3) antagonists so far described. The derivatives with higher affinity at human A(3) adenosine receptors proved to be antagonists, in the cAMP assay, capable of inhibiting the effect of IB-MECA with IC(50) values in the nanomolar range, with a trend strictly
    先前已经报道了以初步形式(Baraldi等人,J.Med.Chem.1999,42,4473-4478)作为高效和选择性的人A(3)腺苷受体拮抗剂的一系列吡唑并三唑并嘧啶类化合物。合成的化合物显示在亚纳摩尔范围内的A(3)腺苷受体亲和力和在人类A(1),A(2A),A(2B)和A(3)腺苷的放射性配体结合测定中评估的高水平选择性受体。特别是,分析了该链在N(8)吡唑氮上的作用。这项研究使我们能够鉴定出在N(8)吡唑具有甲基的衍生物与在N(5)位置具有4-甲氧基苯基氨基甲酰基部分的衍生物是在亲和力和选择性(hA)方面均具有最佳结合特性的化合物(3)= 0.2 nM,hA(1)/ hA(3)= 5485,hA(2A)/ hA(3)= 6950,hA(2B)/ hA(3)= 1305)。在特定功能模型中,所有化合物均被证明是完全拮抗剂,其中在稳定转染了人A(3)受体的CHO细胞膜中测量了IB-M
  • Synthesis of the tritium labeled SCH 58261, a new non-xanthine A2A adenosine receptor antagonist
    作者:Pier Giovanni Baraldi、Barbara Cacciari、Silvio Dionisotti、Judith Egan、Giampiero Spalluto、Cristina Zocchi
    DOI:10.1002/(sici)1099-1344(199608)38:8<725::aid-jlcr885>3.0.co;2-g
    日期:1996.8
    The tritium labeled form of 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e] 1,2,4-triazolo[1,5-c]pyrimidine (H-3-SCH 58261) was obtained by reduction of 5-amino-7-[2-(2',4',5'-tribromo)-phenylethyl]-2-(2-furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine with tritium gas in the presence of 10% Pd-C. Final product was purified by HPLC to give the title H-3-SCH 58261 with radiochemical purity of 99% and specific activity of 68.6 Ci/mmol. H-3-SCH 58261 bound A(2A) receptors in rat striatal membranes (specific binding > 90%) with K-d acid B-max value of 0.70 nM and 971 fmol/mg of protein, respectively. H-3-SCH 58261 represents a useful tool for a further characterization of A(2A) adenosine receptor subtype.
查看更多

同类化合物

阿扎次黄嘌呤 钠2-氨基-6-甲基-[1,2,4]三唑并[1,5-a]嘧啶-5-醇 替格瑞洛 曲匹地尔 异亚丙基替卡格雷 布美地尔 唑嘧菌胺 唑嘧磺草胺 去羟基乙氧基替格雷洛 化合物 T15173 v-三唑并[4,5-d]嘧啶,(3H),3-环戊基-7-偏基硫代- [[[3-(4,7-二氢-7-氧代-1H-1,2,3-三唑并[4,5-d]嘧啶-5-基)-4-丙氧基苯基]氨基]亚甲基]丙二酸二乙酯 [1,2,4]噻唑并[1,5-c]嘧啶-5(6h)-酮 [1,2,4]三氮唑并[1,5-A]嘧啶-2-胺 [1,2,4]三唑并[3,4-f]嘧啶 [1,2,4]三唑并[1,5-A]嘧啶-2-羧酸甲酯 [1,2,4]三唑并[1,5-A]嘧啶-2-羧酸 [1,2,4]三唑[1,5,A]嘧啶-7-氨基 [(1R,3S)-3-(5-氨基-7-氯-3H-[1,2,3]三唑并[4,5-d]嘧啶-3-基)环戊基]甲醇 [(1R,3S)-3-(5,7-二氨基-3H-[1,2,3]三唑并[4,5-d]嘧啶-3-基)环戊基]甲醇 N-甲基-1H-1,2,3-三唑并[4,5-d]嘧啶-7-胺 N-(4'-氟丁酰苯)-4-(4-氯苯基)吡啶正离子 N-(2,6-二氯苯基)-5,7-二甲基[1,2,4]三唑并[1,5-a]嘧啶-2-磺酰胺 N-(2,6-二氯-3-甲苯基)-5,7-二甲氧基-[1,2,4]三唑[1,5-a]嘧啶-2-磺酰胺 N-(2,6-二氯-3-甲基苯基)-5,7-二氯-1,2,4-三唑并[1,5-a]吡啶-2-磺酰胺 N-(1,5,6,7-四氢-3,6-二甲基-5,7-二氧代-1,2,4-三唑并[4,3-c]嘧啶-8-基)-乙酰胺 EED抑制剂(EEDINHIBITOR-1) 9H-7,8-二氢-(1,2,3)三唑并(4',5'-4,5)嘧啶并(6,1-b)(1,3)噻嗪-5(3H)-酮 9-乙基-2,4,7,8,9-五氮杂双环[4.3.0]壬-1,3,5,7-四烯-3,5-二胺 8-甲氧基-3-甲基-[1,2,4]三唑并[4,3-C]嘧啶 8-甲基-1,3,7,9-四氮杂双环[4.3.0]壬-2,4,6,8-四烯 8-溴-[1,2,4]三唑并[4,3-c]嘧啶 8-溴-5-(甲硫基)[1,2,4]三唑并[4,3-c]嘧啶 8-氮鸟嘌呤 8-氮杂黄嘌呤 8-氮杂腺嘌呤 8-氮杂-2,6-二氨基嘌呤硫酸盐 8-乙氧基-5-甲氧基[1,2,4]三唑并[1,5-c]嘧啶-2-胺 8-乙基-4-甲基-1,3,7,9-四氮杂双环[4.3.0]壬-2,4,6,8-四烯 7H-[1,2,3]三唑并[4,5-d]嘧啶 7-(2-呋喃基)[1,2,4]三唑并[1,5-a]嘧啶-2-基胺 7-羟基-5-甲基-2(甲硫基)-1,2,4-三唑并[1,5-a]嘧啶-6-羧酸乙酯 7-羟基-5-甲基-1,3,4-三氮吲哚利嗪 7-甲基[1,2,4]三唑并[4,3-A]嘧啶-3-羧酸 7-甲基[1,2,4]三唑并[1,5-a]嘧啶-5-醇 7-甲基-[1,2,4]噻唑并[4,3-c]嘧啶 7-甲基-8-丙基-[1,2,4]噻唑并[1,5-c]嘧啶 7-环丙基[1,2,4]三唑[1,5-a]嘧啶-2-胺 7-氯-[1,2,4]噻唑并[1,5-c]嘧啶 7-氯-[1,2,4]噻唑并[1,5-a]嘧啶